FierceBiotech

Microbix And Therapure Biopharma Form Partnership To Expand Water-Based Supplies To The Pharma Industry

In the agreement between the two Toronto-area companies, Microbix will maintain sales and marketing functions while Therapure will manage manufacturing, distribution ...
Business Wire

Therapure Innovations Receives FDA Approval to Proceed with a Phase 1 Clinical Trial of Its Novel Anemia Therapeutic TBI 304H

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Innovations, a division of Therapure Biopharma Inc., today announces that the U.S. Food and Drug Administration (FDA) has given the Company approval to ...
PE Hub

Catalyst-owned Therapure delays IPO citing market conditions

MISSISSAUGA, ON, Feb. 4, 2016 /CNW/ – Therapure Biopharma Inc. (“Therapure”) today announced that its proposed initial public offering is being postponed due to current conditions in capital markets.
Business Wire

Therapure Innovations Receives FDA Approval to Proceed with a Phase 1 Clinical Trial of the Targeted Liver Cancer Therapeutic TBI 302

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Innovations, a division of Therapure Biopharma Inc., today announces that the U.S. Food and Drug Administration (FDA) has given the company approval to ...
technologynetworks

Therapure Biopharma to Acquire Plasma Protein Purification Technology

Therapure Biopharma Inc. and Upfront Chromatography A/S have announced that they have entered into an agreement for Therapure to acquire the assets and associated business related to human plasma ...
Newswire

Microbix And Therapure Biopharma Form Partnership To Expand Water-Based

In the agreement between the two Toronto-area companies, Microbix will maintain sales and marketing functions while Therapure will manage manufacturing, distribution and product development TORONTO , ...